title: Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.
abstract: The clinical significance of hepatitis B virus (HBV) genotypes is still under debate. The aims of this study were to assess the distribution of HBV genotypes in France and to identify the associations between HBV genotypes and patient demographics, severity of liver disease and HBeAg status in patients referred to tertiary care centres. This was a French, multicentre, retrospective study on 262 patients with chronic HBV infection. HBV genotypes were determined using INNO-LiPA. Liver fibrosis damage was evaluated by histological analysis of biopsy samples. Patients were mainly male (74%), of Caucasian (65%), Asian (17%) or African (18%) ethnicity and 36% were HBeAg positive. All A-G genotypes were found, the most frequent being genotypes D (27%) and A (24%), followed by E (13%) and C (12%), and B (7%). Mixed genotypes were detected in 16% of the cases. Genotype A was associated with sexual contact (P < 0.001) and genotype D with transfusion (P < 0.001) and HBe antibody positivity (P = 0.03).The distribution of HBV genotypes differed with regard to the ethnicity, and may reflect migration patterns. Genotypes A and D were the most frequent in France. Genotype A was associated with HBeAg positivity and genotype D with HBe antibody positivity. In our European patients, we find no clear association between a given HBV genotype and liver disease severity.
authors.affiliation: Alphabio Laboratory, Marseille, France. alphabio@wanadoo.fr
authors.forename: P
authors.initials: P
authors.lastname: Halfon
authors.forename: M
authors.initials: M
authors.lastname: Bourlière
authors.forename: S
authors.initials: S
authors.lastname: Pol
authors.forename: Y
authors.initials: Y
authors.lastname: Benhamou
authors.forename: D
authors.initials: D
authors.lastname: Ouzan
authors.forename: M
authors.initials: M
authors.lastname: Rotily
authors.forename: H
authors.initials: H
authors.lastname: Khiri
authors.forename: C
authors.initials: C
authors.lastname: Renou
authors.forename: G
authors.initials: G
authors.lastname: Pénaranda
authors.forename: D
authors.initials: D
authors.lastname: Saadoun
authors.forename: V
authors.initials: V
authors.lastname: Thibault
authors.forename: J
authors.initials: J
authors.lastname: Serpaggi
authors.forename: M
authors.initials: M
authors.lastname: Varastet
authors.forename: M-H
authors.initials: MH
authors.lastname: Tainturier
authors.forename: T
authors.initials: T
authors.lastname: Poynard
authors.forename: P
authors.initials: P
authors.lastname: Cacoub
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D003430:Cross-Sectional Studies; D005260:Female; D005602:France; D005838:Genotype; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000201:enzymology / Q000276:immunology / Q000473:pathology / Q000821:virology*; D006651:Histocytochemistry; D006801:Humans; D008103:Liver Cirrhosis / Q000201:enzymology / Q000276:immunology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D000410:Alanine Transaminase